Bio-Techne Corporation
TECH
$60.24
$1.773.02%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.89M | 33.60M | 40.59M | 49.06M | 27.47M |
| Total Depreciation and Amortization | 27.08M | 28.14M | -18.54M | 27.31M | 27.80M |
| Total Amortization of Deferred Charges | -- | -- | 46.60M | -- | -- |
| Total Other Non-Cash Items | 10.18M | 11.89M | 17.09M | 3.29M | 9.07M |
| Change in Net Operating Assets | 12.20M | -9.74M | -10.24M | 1.33M | 18.78M |
| Cash from Operations | 84.35M | 63.89M | 75.50M | 80.99M | 83.12M |
| Capital Expenditure | -6.82M | -9.17M | -17.98M | -16.44M | -14.86M |
| Sale of Property, Plant, and Equipment | 1.79M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -3.28M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -12.51M | 9.17M | 0.00 | -5.53M |
| Cash from Investing | -5.03M | -21.68M | -8.81M | -16.44M | -23.67M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 65.00M |
| Total Debt Repaid | 0.00 | -19.00M | -70.00M | -58.00M | -58.00M |
| Issuance of Common Stock | 5.54M | 25.10M | 22.93M | 18.33M | 5.28M |
| Repurchase of Common Stock | -76.64M | -4.98M | -402.00K | -168.00K | -81.12M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -12.74M | -12.69M | -12.63M | -12.58M | -12.56M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -83.84M | -11.57M | -60.10M | -52.42M | -81.40M |
| Foreign Exchange rate Adjustments | -5.47M | 5.12M | 5.28M | -2.35M | 3.42M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.99M | 35.75M | 11.88M | 9.78M | -18.53M |
